EN
AR
Core Mobile Precision guided therapy system
Core Mobile Precision guided therapy system
This product is no longer available

Core Mobile

Precision guided therapy system

This product is no longer available

Find similar products

Core Mobile is designed to power the future of precision guided therapy and offers the choice of imaging and physiology on a single mobile platform.¹ Core Mobile also provides clarity in your approach and confidence in your results by offering additional information during the diagnostic phase, assisting in intervention decisions.

Specifications

Power requirements
Power requirements
System input
  • 100, 120V or 240VAC, 50/60Hz, 1000VA
Dimensions
Dimensions
Core Mobile
  • H=62", W=22", D=33" Inches
Control Pad (optional)
  • H=2.75", W=10.5", D=8.3" Inches
Ordering information
Ordering information
Core Mobile 120V
  • COREmb120
Control Pad
  • CPADO1
Bedrail mount
  • MNTO1
Monitor mount
  • MNTO2
Power requirements
Power requirements
System input
  • 100, 120V or 240VAC, 50/60Hz, 1000VA
Dimensions
Dimensions
Core Mobile
  • H=62", W=22", D=33" Inches
Control Pad (optional)
  • H=2.75", W=10.5", D=8.3" Inches
See all specifications
Power requirements
Power requirements
System input
  • 100, 120V or 240VAC, 50/60Hz, 1000VA
Dimensions
Dimensions
Core Mobile
  • H=62", W=22", D=33" Inches
Control Pad (optional)
  • H=2.75", W=10.5", D=8.3" Inches
Ordering information
Ordering information
Core Mobile 120V
  • COREmb120
Control Pad
  • CPADO1
Bedrail mount
  • MNTO1
Monitor mount
  • MNTO2
  • 1. 505-0100.21, Operator's Manual, Core Integrated, 3.4X (p. 18); 505-0101.16, Operator's Manual, s5 Series FFR_iFR Option, v3.4x (p.15).
  • 2. VAL RPT, S5-Core V3.4 SW with Core Control Pad, 215-0007.02.
  • 3. Product Spec. 809480-001, 202-0407.01.
  • 4. Requirements Specification Meridian VH SW, 806000-004 (pg 84).
  • 5. An iFR cut-point of 0.89 matches best with an FFR ischemic cut-point of 0.80 with a specificity of 87.8% and sensitivity of 73.0%. (iFR Operator’s Manual 505-0101.23)
  • 6. N Engl J Med. 2012;367(11):991-1001.
  • 7. Witzenbichler B et al. Relationship Between Intravascular Ultrasound Guidance and Clinical Outcomes After Drug-Eluting Stents: The ADAPT-DES Study. Circulation 2014 Jan: 129,4;463-470
  • 8. Ahn et al. Meta-Analysis of Outcomes After Intravascular Ultrasound Guided Versus Angiography-Guided Drug-Eluting Stent Implantation in 26,503 Patients Enrolled in Three Randomized Trials and 14 Observational Studies. Am J Cardiol 2014; 113:1338-1347
  • 9. Nair A, Margolis M, Kuban B, Vince D. Automated Coronary Plaque Characterisation with Intravascular Ultrasound Backscatter: Ex Vivo Validation. EuroIntervention. 2007; 3: 113-120
  • *Safety and efficacy of VH IVUS for use in the characterization of vascular lesions and tissue types has not been established
  • Product availability is subject to country regulatory clearance. Please contact your local sales representative to check the availability in your country.
  • Always read the label and follow the directions for use.
  • Philips medical devices should only be used by physicians and teams trained in interventional techniques, including training in the use of this device.
  • Philips reserves the right to change product specifications without prior notification.
  • ©2025 Koniklijke Philips N.V. All rights reserved. Trademarks are the property of Koninklijke Philips N.V. or their respective owners.

You are about to visit a Philips global content page

Continue

Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.